Core Insights - Catheter Precision, Inc. has received notification from the United States Patent and Trademark Office regarding the allowance for two new patents, enhancing its intellectual property portfolio in the cardiac electrophysiology market [1][4]. Patent Details - The first patent is titled "Methods of Ventricular Arrhythmia Localization Using a 3D Model," which will be assigned to Kardionav, a joint venture aimed at developing new applications for cardiac ventricular therapies [2]. - The second patent, "Neurostimulation Devices and Methods," focuses on improving cardiac ventricular function, particularly for heart failure patients, and will be assigned to Cardionomix, a subsidiary of Catheter Precision [3]. Company Overview - Catheter Precision is a U.S.-based medical device company dedicated to innovating solutions for cardiac arrhythmias, emphasizing collaboration with physicians and continuous product advancement [6]. - The company's VIVO technology is a non-invasive 3D imaging system that helps identify the origins of ventricular arrhythmias before procedures, thereby improving workflow and reducing procedure time [5].
Catheter Precision, Inc. Announces Two New Patents to be Issued by USPTO